Author Müller, Marcel A.
-
2011 | Journal Article
Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
Kühl, A.; Hoffmann, M.; Müller, M. A.; Munster, V. J.; Gnirß, K.; Kiene, M. & Tsegaye, T. S. et al. (2011)
The Journal of Infectious Diseases, 204(suppl_3) pp. S840-S849. DOI: https://doi.org/10.1093/infdis/jir306
Details DOI
-
2011 | Journal Article
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Glowacka, I.; Bertram, S.; Müller, M. A.; Allen, P.; Soilleux, E.; Pfefferle, S. & Steffen, I. et al. (2011)
Journal of Virology, 85(9) pp. 4122-4134. DOI: https://doi.org/10.1128/JVI.02232-10
Details DOI
-
2011 | Journal Article | Research Paper
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease
Bertram, S.; Glowacka, I.; Müller, M. A.; Lavender, H.; Gnirss, K.; Nehlmeier, I. & Niemeyer, D. et al. (2011)
Journal of Virology, 85(24) pp. 13363-13372. DOI: https://doi.org/10.1128/JVI.05300-11
Details DOI PMID PMC
-
2017 | Journal Article |
Factors determining human-to-human transmissibility of zoonotic pathogens via contact
Richard, M.; Knauf, S.; Lawrence, P.; Mather, A. E.; Munster, V. J.; Müller, M. A. & Smith, D. et al. (2017)
Current Opinion in Virology, 22 pp. 7-12. DOI: https://doi.org/10.1016/j.coviro.2016.11.004
Details DOI PMID PMC
-
2019 | Journal Article
Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization
Kleine-Weber, H.; Elzayat, M. T.; Wang, L.; Graham, B. S.; Müller, M. A.; Drosten, C. & Pöhlmann, S. et al. (2019)
Journal of Virology, 93(2). DOI: https://doi.org/10.1128/JVI.01381-18
Details DOI
-
2020 | Journal Article
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Prokscha, A.; Naim, H. Y.; Müller, M. A. & Drosten, C. et al. (2020)
Emerging Microbes & Infections, 9(1) pp. 155-168. DOI: https://doi.org/10.1080/22221751.2020.1713705
Details DOI
-
2020 | Journal Article
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Hoffmann, M.; Schroeder, S.; Kleine-Weber, H.; Müller, M. A.; Drosten, C. & Pöhlmann, S. (2020)
Antimicrobial Agents and Chemotherapy, 64(6). DOI: https://doi.org/10.1128/AAC.00754-20
Details DOI
-
2020 | Journal Article
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S. & Schiergens, T. S. et al. (2020)
Cell, 181(2) pp. 271-280.e8. DOI: https://doi.org/10.1016/j.cell.2020.02.052
Details DOI
-
2020 | Journal Article |
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Hoffmann, M.; Mösbauer, K.; Hofmann-Winkler, H.; Kaul, A.; Kleine-Weber, H.; Krüger, N. & Gassen, N. C. et al. (2020)
Nature, 585(7826) pp. 588-590. DOI: https://doi.org/10.1038/s41586-020-2575-3
Details DOI